Fig 2. Explanatory power of varying MeCP2 levels (in vitro and in vivo).
(A) Fraction of variance explained by regressing splicing variation against sequence features combined with MeCP2 binding in cultured human neurons [9]. (B) Fraction of variance explained by regressing splicing variation against sequence features combined with changes in DNA methylation in WT and MeCP2 KO mouse brain [17].